List of Tables
Table 1. Global Rifaximin Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Rifaximin Capsules Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Rifaximin Capsules Market Competitive Situation by Manufacturers in 2023
Table 4. Global Rifaximin Capsules Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Rifaximin Capsules Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Rifaximin Capsules Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Rifaximin Capsules Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Rifaximin Capsules Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Rifaximin Capsules, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Rifaximin Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rifaximin Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Rifaximin Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rifaximin Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rifaximin Capsules as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rifaximin Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Rifaximin Capsules Sales by Region (2019-2024) & (K Units)
Table 18. Global Rifaximin Capsules Sales Market Share by Region (2019-2024)
Table 19. Global Rifaximin Capsules Sales by Region (2025-2030) & (K Units)
Table 20. Global Rifaximin Capsules Sales Market Share by Region (2025-2030)
Table 21. Global Rifaximin Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Rifaximin Capsules Revenue Market Share by Region (2019-2024)
Table 23. Global Rifaximin Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Rifaximin Capsules Revenue Market Share by Region (2025-2030)
Table 25. North America Rifaximin Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Rifaximin Capsules Sales by Country (2019-2024) & (K Units)
Table 27. North America Rifaximin Capsules Sales by Country (2025-2030) & (K Units)
Table 28. North America Rifaximin Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Rifaximin Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Rifaximin Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Rifaximin Capsules Sales by Country (2019-2024) & (K Units)
Table 32. Europe Rifaximin Capsules Sales by Country (2025-2030) & (K Units)
Table 33. Europe Rifaximin Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Rifaximin Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Rifaximin Capsules Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Rifaximin Capsules Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Rifaximin Capsules Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Rifaximin Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Rifaximin Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Rifaximin Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Rifaximin Capsules Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Rifaximin Capsules Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Rifaximin Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Rifaximin Capsules Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Rifaximin Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Rifaximin Capsules Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Rifaximin Capsules Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Rifaximin Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Rifaximin Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Rifaximin Capsules Sales (K Units) by Type (2019-2024)
Table 51. Global Rifaximin Capsules Sales (K Units) by Type (2025-2030)
Table 52. Global Rifaximin Capsules Sales Market Share by Type (2019-2024)
Table 53. Global Rifaximin Capsules Sales Market Share by Type (2025-2030)
Table 54. Global Rifaximin Capsules Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Rifaximin Capsules Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Rifaximin Capsules Revenue Market Share by Type (2019-2024)
Table 57. Global Rifaximin Capsules Revenue Market Share by Type (2025-2030)
Table 58. Global Rifaximin Capsules Price (US$/Unit) by Type (2019-2024)
Table 59. Global Rifaximin Capsules Price (US$/Unit) by Type (2025-2030)
Table 60. Global Rifaximin Capsules Sales (K Units) by Application (2019-2024)
Table 61. Global Rifaximin Capsules Sales (K Units) by Application (2025-2030)
Table 62. Global Rifaximin Capsules Sales Market Share by Application (2019-2024)
Table 63. Global Rifaximin Capsules Sales Market Share by Application (2025-2030)
Table 64. Global Rifaximin Capsules Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Rifaximin Capsules Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Rifaximin Capsules Revenue Market Share by Application (2019-2024)
Table 67. Global Rifaximin Capsules Revenue Market Share by Application (2025-2030)
Table 68. Global Rifaximin Capsules Price (US$/Unit) by Application (2019-2024)
Table 69. Global Rifaximin Capsules Price (US$/Unit) by Application (2025-2030)
Table 70. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information
Table 71. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Description and Business Overview
Table 72. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin Capsules Product
Table 74. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Developments/Updates
Table 75. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information
Table 76. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Rifaximin Capsules Product
Table 79. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Southwest Pharmaceutical Co., Ltd. Company Information
Table 81. Southwest Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Southwest Pharmaceutical Co., Ltd. Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Southwest Pharmaceutical Co., Ltd. Rifaximin Capsules Product
Table 84. Southwest Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Hainan Sanye Pharmaceutical Factory Co., Ltd. Company Information
Table 86. Hainan Sanye Pharmaceutical Factory Co., Ltd. Description and Business Overview
Table 87. Hainan Sanye Pharmaceutical Factory Co., Ltd. Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Hainan Sanye Pharmaceutical Factory Co., Ltd. Rifaximin Capsules Product
Table 89. Hainan Sanye Pharmaceutical Factory Co., Ltd. Recent Developments/Updates
Table 90. Aden Healthcare Company Information
Table 91. Aden Healthcare Description and Business Overview
Table 92. Aden Healthcare Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Aden Healthcare Rifaximin Capsules Product
Table 94. Aden Healthcare Recent Developments/Updates
Table 95. Estrellas Life Sciences Private Limited Company Information
Table 96. Estrellas Life Sciences Private Limited Description and Business Overview
Table 97. Estrellas Life Sciences Private Limited Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Estrellas Life Sciences Private Limited Rifaximin Capsules Product
Table 99. Estrellas Life Sciences Private Limited Recent Developments/Updates
Table 100. Alfasigma SpA Company Information
Table 101. Alfasigma SpA Description and Business Overview
Table 102. Alfasigma SpA Rifaximin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Alfasigma SpA Rifaximin Capsules Product
Table 104. Alfasigma SpA Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Rifaximin Capsules Distributors List
Table 108. Rifaximin Capsules Customers List
Table 109. Rifaximin Capsules Market Trends
Table 110. Rifaximin Capsules Market Drivers
Table 111. Rifaximin Capsules Market Challenges
Table 112. Rifaximin Capsules Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Rifaximin Capsules
Figure 2. Global Rifaximin Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Rifaximin Capsules Market Share by Type: 2023 & 2030
Figure 4. 0.1g Product Picture
Figure 5. 0.2g Product Picture
Figure 6. Global Rifaximin Capsules Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Rifaximin Capsules Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Rifaximin Capsules Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Rifaximin Capsules Market Size (2019-2030) & (US$ Million)
Figure 13. Global Rifaximin Capsules Sales (2019-2030) & (K Units)
Figure 14. Global Rifaximin Capsules Average Price (US$/Unit) & (2019-2030)
Figure 15. Rifaximin Capsules Report Years Considered
Figure 16. Rifaximin Capsules Sales Share by Manufacturers in 2023
Figure 17. Global Rifaximin Capsules Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Rifaximin Capsules Players: Market Share by Revenue in Rifaximin Capsules in 2023
Figure 19. Rifaximin Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Rifaximin Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Rifaximin Capsules Sales Market Share by Country (2019-2030)
Figure 22. North America Rifaximin Capsules Revenue Market Share by Country (2019-2030)
Figure 23. United States Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Rifaximin Capsules Sales Market Share by Country (2019-2030)
Figure 26. Europe Rifaximin Capsules Revenue Market Share by Country (2019-2030)
Figure 27. Germany Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Rifaximin Capsules Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Rifaximin Capsules Revenue Market Share by Region (2019-2030)
Figure 34. China Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Rifaximin Capsules Sales Market Share by Country (2019-2030)
Figure 42. Mexico Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Rifaximin Capsules Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Rifaximin Capsules Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Rifaximin Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Rifaximin Capsules by Type (2019-2030)
Figure 52. Global Revenue Market Share of Rifaximin Capsules by Type (2019-2030)
Figure 53. Global Rifaximin Capsules Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Rifaximin Capsules by Application (2019-2030)
Figure 55. Global Revenue Market Share of Rifaximin Capsules by Application (2019-2030)
Figure 56. Global Rifaximin Capsules Price (US$/Unit) by Application (2019-2030)
Figure 57. Rifaximin Capsules Value Chain
Figure 58. Rifaximin Capsules Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
